Announcements Trials
Browse Landscape

Phase

Phase 2 18Phase 1 10Phase NA 6Phase 1/2 5Phase 3 3Phase 4 1Phase 2/3 1

Status

Terminated 2Completed 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 1

Conditions

Tuberous Sclerosis 1Prostatic Neoplasms 1Adenomatous Polyps 1Adenoma 1

Interventions

Cisplatin 725Carboplatin 607Paclitaxel 578Cyclophosphamide 516Radiotherapy 511Docetaxel 475Fluorouracil 453Gemcitabine 437Doxorubicin 383Capecitabine 361Dexamethasone 327Oxaliplatin 288pembrolizumab 283Leucovorin 282Bevacizumab 275Etoposide 271Vincristine 270Rituximab 246Prednisone 222Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 175Irinotecan 172Methotrexate 171Lenalidomide 137Nivolumab 135Filgrastim 135Epirubicin 129Tamoxifen 127

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Calcitriol × Clear all
NCT00486512 2020-09-03

Chemoprevention of Colorectal Adenomas

Colotech A/S

Phase 3 Terminated
350 enrolled

Adenoma, Adenomatous Polyps

NCT03140449 2017-05-04

Topical Rapamycin and Calcitriol for Angiofibroma of Tuberous Sclerosis

National Taiwan University Hospital

Phase 3 Completed
52 enrolled

Tuberous Sclerosis

NCT00273338 2007-11-06

DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2])

Novacea

Phase 3 Terminated
1,200 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡